XFOR Smart Money
X4 Pharmaceuticals, Inc.
1W: +7.6%
1M: +7.6%
3M: -18.8%
YTD: -16.4%
1Y: -14.5%
3Y: -86.8%
5Y: -97.8%
$3.25
+0.00 (+0.00%)
Weekly Expected Move ±10.4%
$3
$3
$3
$4
$4
Credit Risk of going bust: higher than 73% of companies Debt: 19.3% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the third-riskiest tenth, about 1 in 140 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.10 (down 97%), X4 Pharmaceuticals, Inc. would be worth roughly what it owes.
Total debt $77.2M against a stock market value of $322.2M.
Distance to default 3.19 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $38.4M (short-term plus half of long-term), stock volatility 72.2%; Altman Z'' -3.45. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.10 (down 97%), X4 Pharmaceuticals, Inc. would be worth roughly what it owes.
Total debt $77.2M against a stock market value of $322.2M.
Distance to default 3.19 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $38.4M (short-term plus half of long-term), stock volatility 72.2%; Altman Z'' -3.45. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
🏦 Institutional Activity
Latest: Q2 2026116
Institutions Holding
+25 vs prior
139.3%
Ownership
+23.31%
34
New
23
Increased
39
Reduced
26
Closed
👔 Insider Trades
19 records| Date | Name | Title | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-10-16 | Craig Adam R | officer: executive chairman | P-Purchase | 4,600 | $2.58 | $12K | Filing |
| 2026-10-01 | KIRSKE DAVID | officer: chief financial officer | S-Sale | 11,767 | $2.86 | $34K | Filing |
| 2026-08-12 | Craig Adam R | officer: executive chairman | S-Sale | 47,436 | $4.44 | $211K | Filing |
| 2026-08-12 | Volpone John | officer: president | S-Sale | 24,576 | $4.44 | $109K | Filing |
| 2026-06-30 | KIRSKE DAVID | officer: chief financial officer | S-Sale | 8,543 | $4.26 | $36K | Filing |
| 2026-05-12 | KIRSKE DAVID | officer: chief financial officer | S-Sale | 16,961 | $4.29 | $73K | Filing |
| 2025-10-23 | Craig Adam R | officer: executive chairman | P-Purchase | 86,206 | $2.90 | $250K | Filing |
| 2025-08-14 | Craig Adam R | officer: executive chairman | A-Grant/Award | 289,881 | $— | $0 | Filing |
| 2025-08-14 | KIRSKE DAVID | officer: chief financial officer | A-Grant/Award | 193,254 | $— | $0 | Filing |
| 2025-08-14 | Volpone John | officer: president | A-Grant/Award | 289,881 | $— | $0 | Filing |
| 2025-06-09 | Bridger Gary | director | A-Grant/Award | 1,500 | $— | $0 | Filing |
| 2025-06-09 | MCGIRR DAVID W J | director | A-Grant/Award | 1,500 | $— | $0 | Filing |
| 2025-06-09 | Stewart Murray | director | A-Grant/Award | 1,500 | $— | $0 | Filing |
| 2025-06-09 | WYZGA MICHAEL S | director | A-Grant/Award | 1,500 | $— | $0 | Filing |
| 2025-06-09 | Woods Keith | director | A-Grant/Award | 1,500 | $— | $0 | Filing |
| 2025-06-09 | de Craecker Francoise | director | A-Grant/Award | 1,500 | $— | $0 | Filing |
| 2025-05-20 | Thoren Natasha Fay | officer: chief legal officer | A-Grant/Award | 3,333 | $— | $0 | Filing |
| 2025-05-16 | Baldry Mark | officer: chief commercial officer | P-Purchase | 1,032 | $2.48 | $3K | Filing |
| 2025-05-16 | Baldry Mark | officer: chief commercial officer | A-Grant/Award | 1,032 | $2.48 | $3K | Filing |
🏛️ Congressional Trades
0 records| Date | Politician | Chamber | Type | Amount | Filing |
|---|---|---|---|---|---|
| No congressional trades found | |||||
🏦 Top Institutional Holders
20 holders| Holder | Shares | Value | Date Reported | Filing | |
|---|---|---|---|---|---|
| MORGAN STANLEY | 9,461,279 | $44M | -5,713 | 2026-06-30 | Filing |
| FMR LLC | 8,321,657 | $39M | +218,257 | 2026-06-30 | Filing |
| Bain Capital Life Sciences Investors, LL | 7,967,454 | $37M | — | 2026-06-30 | Filing |
| PERCEPTIVE ADVISORS LLC | 7,933,491 | $37M | +1,195,843 | 2026-06-30 | Filing |
| Saturn V Capital Management LP | 6,973,343 | $33M | +516,697 | 2026-06-30 | Filing |
| Empery Asset Management, LP | 6,930,591 | $32M | -2,013,527 | 2026-06-30 | Filing |
| Deep Track Capital, LP | 5,878,757 | $27M | -460,778 | 2026-06-30 | Filing |
| BlackRock, Inc. | 5,554,906 | $26M | +4,343,112 | 2026-06-30 | Filing |
| Kalehua Capital Management LLC | 3,722,840 | $17M | — | 2026-06-30 | Filing |
| VANGUARD CAPITAL MANAGEMENT LLC | 3,715,859 | $17M | +218,247 | 2026-06-30 | Filing |
| Rosalind Advisors, Inc. | 3,214,766 | $15M | — | 2026-06-30 | Filing |
| BRAIDWELL LP | 2,922,754 | $14M | -350,200 | 2026-06-30 | Filing |
| Blackstone Inc. | 2,681,922 | $13M | — | 2026-06-30 | Filing |
| Trails Edge Capital Partners, LP | 2,571,478 | $12M | — | 2026-06-30 | Filing |
| Nantahala Capital Management, LLC | 2,449,468 | $11M | — | 2026-06-30 | Filing |
| BVF INC/IL | 2,233,742 | $10M | — | 2026-06-30 | Filing |
| GEODE CAPITAL MANAGEMENT, LLC | 2,098,047 | $10M | +1,158,321 | 2026-06-30 | Filing |
| Venrock Adviser, LLC | 1,934,253 | $9M | +1,603,728 | 2026-06-30 | Filing |
| SAMSARA BIOCAPITAL, LLC | 1,395,587 | $7M | -436,979 | 2026-06-30 | Filing |
| STATE STREET CORP | 1,296,017 | $6M | +892,483 | 2026-06-30 | Filing |